● Recruiting

The Efficacy of Fluticasone Furoate/Vilanterol/Umeclidinium Compared With Vilanterol/Umeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPD

Condition: COPD · Sponsor: Mahidol University

PhasePhase 3

Planned participants50

Who can joinAll sexes, 40 Years to 80 Years

Healthy volunteersNo

About this study

This study aims to demonstrate the effects of triple therapy (ICS/LABA/LAMA) and dual bronchodilators (LAMA/LABA) on air trapping in the lungs' COPD patients and inflammatory mediators

This description comes directly from the study's public registry record.

Talk to the study team

kittipong maneechotesuwan, MD, PhD. · 0894996858 · kittipong.man@mahidol.ac.th

Always discuss trial participation with your own doctor first.

Locations (1)

Division of Respiratory Disease and TB, Siriraj Hospital

Bangkoknoi, BKK, Thailand

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06474039